Prognostic value of albumin-to-globulin ratio in COVID-19 patients: A systematic review and meta-analysis. Issue 5 (May 2022)
- Record Type:
- Journal Article
- Title:
- Prognostic value of albumin-to-globulin ratio in COVID-19 patients: A systematic review and meta-analysis. Issue 5 (May 2022)
- Main Title:
- Prognostic value of albumin-to-globulin ratio in COVID-19 patients: A systematic review and meta-analysis
- Authors:
- Ulloque-Badaracco, Juan R.
Mosquera-Rojas, Melany D.
Hernandez-Bustamante, Enrique A.
Alarcón-Braga, Esteban A.
Herrera-Añazco, Percy
Benites-Zapata, Vicente A. - Abstract:
- Abstract: Background and aims: The albumin-to-globulin ratio (AGR) has been used to predict severity and mortality in infectious diseases. The aim of this study is to evaluate the prognostic value of the AGR in COVID-19 patients. Methods: A systematic review and meta-analysis were conducted. We included observational studies assessing the association between the AGR values upon hospital admission and severity or all-cause mortality in COVID-19 patients. In the meta-analyses we used random effect models. Risk of bias was assessed using the Newcastle-Ottawa Scale (NOS). The effect measures were expressed as mean difference (MD) and their 95% confidence intervals (CI). We performed Egger's test and funnel plots to assess the publication bias. Results: The included studies had a total of 11356 patients corresponding to 31 cohort studies. Severe COVID-19 patients had lower AGR values than non-severe COVID-19 patients (mean difference (MD), −0.27; 95% IC, −0.32 to −0.22; p < 0.001; I 2 = 88%). Non-survivor patients with COVID-19 had lower AGR values than survivor patients (MD, −0.29; 95% IC, −0.35 to −0.24; p < 0.001; I 2 = 79%). In the sensitivity analysis, we only included studies with low risk of bias, which decreased the heterogeneity for both outcomes (severity, I 2 = 20%; mortality, I 2 = 5%). Conclusions: Low AGR values upon hospital admission were found in COVID-19 patients with a worse prognosis. Abstract : Albumin, COVID-19, Globulin, Prognosis.
- Is Part Of:
- Heliyon. Volume 8:Issue 5(2022)
- Journal:
- Heliyon
- Issue:
- Volume 8:Issue 5(2022)
- Issue Display:
- Volume 8, Issue 5 (2022)
- Year:
- 2022
- Volume:
- 8
- Issue:
- 5
- Issue Sort Value:
- 2022-0008-0005-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-05
- Subjects:
- Albumin -- COVID-19 -- Globulin -- Prognosis
Research -- Periodicals
Medical sciences -- Periodicals
Natural history -- Periodicals
Social sciences -- Periodicals
Earth sciences -- Periodicals
Physical sciences -- Periodicals
507.2 - Journal URLs:
- http://www.sciencedirect.com/science/journal/24058440/ ↗
http://www.sciencedirect.com/ ↗ - DOI:
- 10.1016/j.heliyon.2022.e09457 ↗
- Languages:
- English
- ISSNs:
- 2405-8440
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21585.xml